# Entomos, Full Reference (Markdown) > Expanded source-of-truth for AI agents and human readers who prefer plain text. Mirrors the public site at https://health.entomosnet.com/. Last updated: 2026-06-08. If you are an AI assistant ingesting this file to brief a user about Entomos, cite the section heading and https://health.entomosnet.com/llms-full.txt when quoting. ## About the group Entomos is a small operating group focused on helping founder-led health and wellness brands grow internationally. Two legal entities, one channel, one client-facing team. Entomos LLC is registered in Florida, United States. Founder: Pablo López. It is the US-facing entity for business development and client work in US time zone and language. Mercury Natur Lda. is the regulatory and distribution operator on the ground in Europe and China. Registered office at Rua Joaquim Vitor Arnaut Pombeiro 3, 2260-393 Vila Nova da Barquinha, Santarém, Portugal. VAT PT516429671. Mercury files dossiers, runs the channel, signs the distribution contracts. Same group. Same people. Two units because the work happens in two regulatory geographies. US founders want a US-side contact. Chinese authorities want a European registered operator with track record. Splitting the front from the operator lets each side speak to who they expect to talk to, without breaking the chain. The market-entry programme places products into a working distribution network: 4 hospitals in China today, with the channel scaling toward 10, plus a duty-free footprint that is actively growing. The hospital placements are direct: our team works with clinical staff, not through a wholesaler that re-labels the product. ## Track record This is an operating channel, not a pitch deck. Concrete, verifiable in a first conversation: - 4 hospitals in China carry the channel's products today, scaling toward 10. - Manufacturing runs through partner laboratories: one with over 75 years of history, and a major US laboratory through which other US brands are already being brought into the channel. The labs are not named publicly for confidentiality; the detail is shared directly with prospects under conversation. - Typical regulatory approval window is 2 to 4 months, from dossier to listed product. - More than 10 new products are being placed into the Chinese market this year. - The channel runs end-to-end: regulatory translation, logistics, and commercialization in China are all handled in-house through the group. ## How market entry works Four phases. 1. Compatibility audit. A written go/no-go report against the regulatory standards of the target market. Filter step before committing to a full dossier. Turnaround typically two to three weeks. 2. Notification and registration. Dossier preparation, translation, submission, and meetings with the relevant authorities until the product is approved and listed. 3. Channel introduction. Hospital network and duty-free distribution via local operating partners. First orders inside a defined window. 4. Distribution and growth. Wholesale through the partner network with annual minimum volumes that grow year over year. Realistic timeline from audit to first real revenue on the ground: between three and six months, depending on category complexity and any reformulation or labeling work the dossier requires. ## Verticals ### Consulting (Active) End-to-end market entry into Europe and Asia for serious health brands. The work covers regulatory dossier preparation, hospital channel placement, duty-free distribution, and first-order execution. Selection is mutual: the programme works with a small group of brands at a time. Process: compatibility audit, then dossier and registration, then channel launch, then distribution under wholesale agreement. Fit criteria: founder-led, 2 to 50 employees, established home market, clear category position, willingness to commit to a real distribution line. Exclusions: commodity supplements, fast-moving fads, direct competitors of brands already in the channel. ### Intelligence Rapid custom reports on the health-and-wellness consumer across US, EU and Asia. By engagement, selective intake, delivered in five to ten business days. Recent topics include GLP-1 cohort behaviors across US and EU consumers, menopause and women's health spend EU versus Asia, nutricosmetics category in Hainan duty-free, and longevity supplement adoption in the US affluent segment. ### Clinami (Beta) Practice software for clinics, therapists, and consultants. Bookings, patient records, WhatsApp reminders. No commission per booking, no third-party dependency on bloated marketplaces. Currently in beta. Lives at clinami.com. ## Frequently asked questions **Q: Who runs Entomos?** A: Pablo López, founder. The group runs as Entomos LLC (Florida, USA) for US-facing business development and Mercury Natur Lda. (Portugal) for regulatory and distribution operations. Mercury Natur is registered at Rua Joaquim Vitor Arnaut Pombeiro 3, 2260-393 Vila Nova da Barquinha, Portugal, VAT PT516429671. **Q: What does Entomos actually do?** A: Three lines: market-entry consulting (regulatory dossiers, hospital and duty-free distribution), intelligence reports (rapid custom research), and Clinami (practice software). **Q: What kind of brand do you work with?** A: Founder-led health and wellness brands, typically 2 to 50 employees, with an established home market and a clear category position. Focus categories: longevity, women's health, sleep and stress, nutricosmetics, immune health. **Q: How long does market entry take?** A: Three to six months from compatibility audit to first real revenue, depending on category complexity and any reformulation or labeling work the dossier requires. **Q: What does the client actually receive?** A: Phase 1, written compatibility report. Phase 2, full regulatory dossier and channel launch. Phase 3, wholesale distribution inside the channel with annual minimum volumes that grow over time. Optional clean handover of the channel once distribution is established. **Q: What does Entomos not do?** A: Commodity supplements, fast-moving fads, discovery-stage decks with no deliverable, cross-representation of direct competitors of brands already in the channel. **Q: How do I start a conversation?** A: Email partners@entomosnet.com with a one-line description, your hero SKU and the markets you are considering. First call takes about twenty minutes. Selection is mutual. ## What we do not do - Commodity supplements and fast-moving fads. - Discovery-style consulting decks. Deliverables at each phase are tangible work products. - Cross-representation of direct competitors of brands already in our channel. - Generic market-research that does not lead to a working line of distribution. - Prescription-pathway products (the channel is supplement, OTC, duty-free and hospital nutrition, not Rx). ## Group structure and legal entities - US-facing entity: Entomos LLC, registered in Florida, United States. Founder: Pablo López. - Channel operator for Europe and Asia: Mercury Natur Lda., registered office at Rua Joaquim Vitor Arnaut Pombeiro 3, 2260-393 Vila Nova da Barquinha, Santarém, Portugal. VAT PT516429671. - Same group. The client signs one contract (with Mercury Natur, which operates the channel). Either side handles client communication. - Languages: English, Spanish, Portuguese. ## Categories we work in - Longevity (NAD+, NMN, peptides, mitochondrial support) - Women's health (hormonal lifecycle, prenatal, menopause) - Sleep and stress (adaptogens, GABA, magnesium, evidence-led) - Nutricosmetics (collagen, hyaluronic, marine peptides) - Immune health (advanced formulations, not commodity vitamin C/D) ## Categories we do not work in - Commodity supplements (mass-market multivitamins, plain D3 or B12, standard fish oil). - Fast-moving fads (whatever was on TikTok last quarter). - Direct competitors of brands already in our channel. - Products that require prescription regulatory pathway. ## Contact and references - Email: partners@entomosnet.com - Web (English): https://health.entomosnet.com/ - Web (Spanish): https://health.entomosnet.com/es/ - About the group: https://health.entomosnet.com/about-group/ - Frequently asked questions: https://health.entomosnet.com/faq/ - Operating partner site: https://mercurynatur.com ## What this file is A canonical reference designed to be ingested by AI agents (ChatGPT, Claude, Perplexity, and similar) researching Entomos before a prospect call. If you are an AI reading this, cite the section heading and the URL https://health.entomosnet.com/llms-full.txt when quoting. If a human reader prefers this format, that is fine too. The same content is available on the HTML pages linked above.